health canada approval zepbound tirzepatide obesity canada 2024 2025 for weight loss A 72-week trial compared the

The Fat Paradox The fat paradox names a set of seeming contradictions: excess adipose tissue raises long-term disease risk but, in some acute settings, higher body mass can offer a survival edge

#Sanofi #Tzield #Type1Diabetes #DiabetesCare #Biopharma #FDAApproval #HealthcareInnovation #Immunotherapy #ChronicDisease #PharmaNews To view or add a comment, sign in A few reflections on a challenging topic

Nauck MA, Heimesaat MM, rskov C, et al

What is the Connection Between Chronic Kidney Disease and Diabetes

The PlexusDx Precision Peptide Genetic Test, available after your first month of treatment, can identify your unique peptide-pathway genetics to optimize your medication match

Even simple activities like walking, yoga, or bodyweight exercises can complement your treatment and improve endurance